[Translated article] Environmental impact of inhaled therapies in a cystic fibrosis unit: Strategies for sustainability
pMDIs were the inhalers with the highest consumption and CF, although their consumption appears to be decreasing, with an increase in the consumption of SMIs.
Authors
- Beatriz García-Palop (ORCID: https://orcid.org/0000-0002-3302-4864)
- Laura Gómez-Ganda (ORCID: https://orcid.org/0000-0003-2441-8607)
- Aurora Fernández-Polo (ORCID: https://orcid.org/0000-0003-4545-8560)
- Arnau Mariscal-Puig
- Alejandro Ábalos-Camacho
Institutions
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.farma.2025.02.002
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00